Scientific resource

Blog

Blog
19/09/2023

Breaking Barriers in Oncology Drug Development: Unveiling the Potential of 3D Cell Models for Drug Discovery

Blog: 3D Cell models are revolutionizing Cancer Drug Development. Here, we present the main advantages to better understand tumor complexity

CADD: computer tools and chemists combine to make better drug leads
Blog
11/07/2023

CADD: computer tools and chemists combine to make better drug leads

Sylvain Lozano, computational chemist, explains the important role these tools play in our drug discovery journey.

Blog
29/06/2023

Why you should consider tumor microenvironment for cancer therapy?

Combination of Tumor microenvironment and modulating therapeutic approaches may be required to overcome the resistance to treatments and prevent tumor recurrence.

Long Covid - Oncodesign Services
Blog
15/06/2023

How to mimic long COVID for drug discovery?

Long COVID is a complex multisystemic condition still poorly understood. Using optimal preclinical models is essential to understand their mechanisms better and develop new treatments.

Blog
17/05/2023

Five Reasons why you should switch to digital PCR (dPCR)

Digital PCR has enhanced characteristics over qPCR across both its Protocols and Applications, including higher precision and sensitivity. Learn more here.

Blog - Covalent drugs and the potential of benzoxaboroles
Blog
09/05/2023

Covalent drugs and the potential of benzoxaboroles

Molecules based on boron and benzoxaboroles are exciting as reversible covalent binders to target the serine and threonine proteome.

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
Blog
12/04/2023

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis

In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.

Blog
02/02/2023

Why do preclinical cancer models still fail in the clinic?

We at Oncodesign Services strive to develop alternative Preclinical Cancer Models to better suit your drug development. Read more about our solutions here.

Oncodesign Services - Dijon
News
14/12/2022

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future

Gut microbes - Microbiome
Blog
08/11/2022

Why studying the gut microbes could help to cure?

We explore the importance of Gut Microbes on our health by discussing five of those Gut-Organ Axis - brain, intestine, liver, lung, and skin. Read more here.